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1. Introduction 
In inorganic chemistry most active research area is 
coordination chemistry. Recently, numbers of coordination metal 
complexes have been synthesized and investigated, which exhibit 
various biological activities [1-5]. Sulpha drugs are largely in used as 
chemotherapeutic agents whose molecular structures contain a 4-
aminobenzene sulfonamide moiety. The Sulpha drugs and their 
derivatives show diverse biological activities like antihypertensive 
agent bosentan [6], antibacterial [7], antiprotozoal [8], antifungal [9], 
anti-inflammatory [10], nonpeptidic vasopressin receptor antagonists 
[11] and translation initiation inhibitors [12]. The reaction of maleic 
anhydride derivatives with sulphanilamide has not been reported for 
metal complaxation so far. Hence, it was thought that maleic anhydride 
and sulphanilamide moieties can put into one molecule frame may 
afford good biological active compound. The present article discuss 
about synthesizes, characterization and biological studies of 4-oxo-4-(4-
sulfamoylphenylamino) but-2-enoic acid (OSPAB). Also its metal 
complexes based on literature serve regarding importance of 
complexes, it was thought to synthesis transition metal complexes of 
prepared ligand in order to improve in biological activity. 
 
2. Experimental 
2.1. Materials and measurements 
All the chemicals used were of laboratory grade received 
from Sigma–Aldrich. Sulphanilamide was prepared according to method 
reported in literature [13]. 1H, 13C and DEPT-135 NMR spectra were 
recorded in CDCl3 at room temperature using a Bruker AVANCE III 500 
MHz (AV 500) multi nuclei solution NMR Spectrometer, TMS was used 
as internal reference. IR spectra were recorded neat by ATR on a 
Thermo Nicolet iS50 FT–IR spectrometer and are reported in cm-1. HR–
MS data were obtained in methanol, with Thermo Scientific Orbitrap 
Elite Mass spectrometer. The elemental contents were determined by 
Thermo Finigen Flash1101 EA (Itally) the metals were determined 
volumetrically by Vogel’s method [13]. To a 100 mg chelate sample, 
each 1 ml of HCl, H2SO4 and HClO4 were added and then 1 g of NaClO4 
was added. The mixture was evaporated to dryness and the resulting 
salt was dissolved in double distilled water and diluted to the mark. 
From this solution the metal content was determined by titration with 
standard EDTA solution. Magnetic susceptibility measurements of the 
synthesized complexes were carried out on Gouy Balance at room 
temperature. Mercury tetrathiocynatocobalate (II) Hg[Co(NCS)4] was 
used as a calibrant. The electronic spectra of complexes in solid were 
recorded on at room temperature. MgO was used as reference. Melting 
point is measured by open capillary method using Sigma Melting Point 
Apparatus.  
2.2. Synthesis of 4-oxo-4-(4-sulfamoylphenylamino) but-2-enoic 
acid (OSPAB) 
The reaction mixture of maleic anhydride (0.01 mole) in 
ethanol and (0.01 mole) sulphanilamide in ethanol was refluxed for 2-3 
hrs. The resulting solid was washed with water, dried and recrystallized 
from MeOH. Yield: 73.24 %, M.P. (193-194°C) was measurement with 
open capillary method and it is uncorrected. IR (cm-1): 2950-2850 (Ar C-
C), 3450-3360 (CONH, NH2), 3430, 1680 (COOH), 1620-1680 (C=C); 1H- 
NMR(δ ppm, 500 MHz, CDCl3): 11.80 (s, 1H, COOH), 8.32 (s, 1H, NH), 
7.71-7.98 (m, 4H, Ar-H), 6.51-6.92 (d, 2H, CH=CH), 3.14 (s, 2H, NH2). 13C 
MNR (δ ppm, 125 MHz, CDCl3): 182.23, 172.62, 152.12, 148.07, 138.20, 
129.38, 127.98. DEPT-135 (δ ppm, 125 MHz, CDCl3): 138.20, 129.38, 
127.98.   
 
Figure 1:  (Scheme 1) Synthesis of OSPAB   
 
 
2.3. Synthesis of metal complexes of 4-oxo-4-(4-
sulfamoylphenylamino) but-2-enoic acid (OSPAB) 
 The metal complexes of OSPAB with Cu2+, Co2+, Zn2+, Mn2+, 
and Ni2+ metal ions were prepared in two steps. All the metal complexes 
were prepared in an identical procedure.  
2.3.1 Preparation of OSPAB solution  
The OSPAB (0.05 mol) was taken in 100 ml beaker and 
formic acid (85% v/v) was added up to slurry formation. To this slurry 
water was added till the complete dissolution of OSPAB. It was diluted 
to 20 ml. 
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2.3.2 Synthesis of OSPAB-metal-complexes 
 In a solution of metal acetate (0.025 mol) in acetone: water 
(50:50 v/v) mixture (40 ml) the 20 ml of above mentioned OSPAB 
solution (i.e. containing 0.05 M OSPAB) was added with vigorous 
stirring at room temperature. The appropriate pH was adjusted by 
addition of sodium acetate for complete precipitation of metal chelate. 
The precipitates were digested on a boiling water bath and filtered off, 
washed by water and air-dried. 
Figure 2: (Scheme – 2) Synthesis of metal complexes of OSPAB 
 
 
Table 1: Analysis of OSAPB ligand and its metal complexes 




C% H% N% S% M% 
Cald Found Cald Found  Cald Found Cald Found Cald Found 
OSPAB 73 44.44 44.42 3.73 3.72 10.37 10.35 11.86 11.84 - - 
(OSPAB)2Cu2+ 65 37.64 37.62 3.45 3.43 8.78 8.76 10.04 10.02 9.97 9.95 
(OSPAB)2Co2+ 62 37.92 37.91 3.48 3.45 8.85 8.83 10.11 10.10 9.31 9.30 
(OSPAB)2Ni2+ 63 37.93 37.92 3.48 3.46 8.85 8.82 10.12 10.11 9.28 9.27 
(OSPAB)2Mn2+ 66 38.16 38.14 3.50 3.48 8.90 8.88 10.18 10.17 8.74 8.72 
(OSPAB)2Zn2+ 62 37.54 37.51 3.44 3.42 8.76 8.74 10.01 10.00 10.23 10.21 
 
2.4. Antibacterial activity 
The synthesized compounds were screened for their 
antibacterial activities against Escherichia coli, Klebsiella pneumoniae, 
Proteus vulgaris, Staphylococcus aureus, and 
Pseudomonas aeruginosa at a concentration of 200 μg ml-1 in 
dimethylsulphoxide by agar diffusion method using streptomycin as 
standard. The minimum inhibitory concentrations (MIC) were detected 
by serial dilution method. The lowest concentration (μg ml-1) of the 
compound, which inhibits the growth of bacteria maximum after 24 h 
inhibition at 37 ºC, was taken as MIC. The stock solution (10-2 M) was 
prepared by dissolving the complex in dimethylsulphoxide and the 
solutions were diluted to different concentrations in the same solvent in 
order to find the MIC values.  
 
3. Results and Discussion 
 The synthesis of 4-oxo-4-(4-sulfamoylphenylamino) but-2-
enoic acid (OSPAB) was performed by a simple reaction of maleic 
anhydride and Sulphanilamide. The resulted OSPAB ligand was an 
amorphous brown powder. The C, H, N contents of OSPAB (Table-1) are 
consistent with the structure predicted (Scheme-1). The IR spectrum of 
OSPAB comprises the important bands of structure.  
 


























6A1g →6A2g 4Eg 
6A1g →4T2g (4G) 
6A1g →4T1g(PG) 
OSPAB-Zn2+ Diamag. -------- --------- 
 
The broad band due to –OH group appeared at 3430 cm-1. In 
this band the inflections are observed at 2970, 2930 and 2850cm-1. The 
NMR spectrum of OSPAB in DMSO indicates that the singlet of 1H at 
11.8 δ ppm due to –COOH group. The aromatic protons are appeared in 
multiplicity at 7.7-7.9 δ. Thus the structure of OSPAB is confirmed as 
shown in Scheme - 1. 
 The metal and C, H, N contents of metal complexes of OSPAB 
(Table - 1) are also consistent with the predicted structure. The results 
show that the metal: ligand (M:L) ratio for all divalent metal chelate is 
1:2. 
 
Table 3:    Antibacterial activity of OSPAB ligand and its metal complexes 
Sample 
Zone of inhibition at 1000 ppm (%) 
Escherichia coli Klebsiella pneumoniae Proteus vulgaris Staphylococcus aureus 
OSPAB 52 57 46 55 
OSPAB-Cu2+ 71 72 68 70 
OSPAB-Co2+ 64 71 68 64 
OSPAB-Ni2+ 59 68 66 67 
OSPAB-Mn2+ 68 58 62 63 
OSPAB-Zn2+ 72 71 57 73 
Ampicillin 82 90 78 86 
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 The infrared spectra of all the complexes are identical and 
suggest the formation of the entire metalocyclic compound by the 
absence of band characteristic of free –OH group of parent OSPAB. The 
other bands are almost at their respectable positions as appeared in the 
spectrum of parent-OSPAB ligand. However, the band due to (M-O) 
band could not be detected as it may appear below the range of 
instrument used. The important IR Spectral data are shown in Table - 2. 
 Magnetic moments of metal complexes are given in Table - 2. 
The diffuse electronic spectrum of Cu2+ complexes shows two broad 
bands around 13205 and 23443 cm-1. The first band may be due to a 
2B1g → 1A1g transition. While the second band may be due to charge 
transfer. The first band shows structures suggesting a distorted 
octahedral structure for the Cu2+ metal complexes.  
The higher value of the magnetic moment of the Cu2+ chelate 
supports the same. The Co2+ metal chelate gives rise to two absorption 
bands at 23725 and 19094 cm-1, which can be assigned 4T1g→ 2T2g, 4T1g→ 
4T1g(P)transitions, respectively. These absorption bands and the µeff 
value indicate an octahedral configuration of the Co2+ metal chelate 
[15]. The spectrum of Mn2+ polymeric chelate comprised two bands at 
19025cm-1 and 23223cm-1. The latter does not have a very long tail. 
These bands may be assigned to 6 A1g→ 4T2g(G) and 6 A1g→ 4A2g(G) 
transitions, respectively. The high intensity of the bands suggests that 
they may have some charge transfer character. The magnetic moment is 
found to be lower than normal range. In the absence of low temperature 
measurement of magnetic moment it is difficult to attach any 
significance to this. The observed µeff values in the range 2.52-5.56 B.M 
are consistent with the above moiety [15]. 
   The examination of antibacterial activity of ligand and its all 
complexes (Table - 3) reveals that the ligand is moderately toxic against 
bacteria, while all the complexes are more toxic than ligand. Among all 
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